EGFR and cancer: A comparative analysis has been conducted based on computational modeling of the wild type (WT) ABL and EGFR kinase domains as well as a panel of clinically important cancer mutants ABL-T315I, ABL-L387M, EGFR-T790M, and EGFR-L858R.